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Abstract: C5-epimerases are promising tools for the production of rare L-hexoses from their more 
common D-counterparts. On that account, UDP-glucuronate 5-epimerase (UGA5E) attracts 
attention as this enzyme could prove to be useful for the synthesis of UDP-L-iduronate. 
Interestingly, L-iduronate is known as a precursor for the production of heparin, an effective 
anticoagulant. To date, the UGA5E specificity has only been detected in rabbit skin extract, and the 
respective enzyme has not been characterized in detail or even identified at the molecular level. 
Accordingly, the current work aimed to shed more light on the properties of UGA5E. Therefore, the 
pool of putative UGA5Es present in the UniProt database was scrutinized and their sequences were 
clustered in a phylogenetic tree. However, the examination of two of these enzymes revealed that 
they actually epimerize UDP-glucuronate at the 4- rather than 5-position. Furthermore, in silico 
analysis indicated that this should be the case for all sequences that are currently annotated as 
UGA5E and, hence, that such activity has not yet been discovered in nature. The detected L-
iduronate synthesis in rabbit skin extract can probably be assigned to the enzyme chondroitin-
glucuronate C5-epimerase, which catalyzes the conversion of D-glucuronate to L-iduronate on a 
polysaccharide level. 
Keywords: UDP-glucuronate 5-epimerase; UDP-glucuronate 4-epimerase; CEP1 family; L-
iduronate; biocatalysis; phylogenetic tree; recombinant expression 
 
1. Introduction 
Carbohydrate epimerases (CEP, EC 5.1.3) catalyze the inversion of the configuration of a chiral 
carbon atom in molecules with more than one stereocenter [1]. Accordingly, they are able to create 
shortcuts in the production of rare sugars starting from their abundant counterparts [2]. Over 30 
different carbohydrate epimerases have been described to date, covering various substrate and 
product specificities. Despite their seemingly simple net reaction, the mechanisms employed by these 
enzymes are diverse and sometimes quite complex. Recently, a comprehensive classification was 
proposed for epimerases, which consists of 14 families (CEP1–CEP14) in which structure and 
mechanism are conserved [3]. Thereof, the CEP1 family is the largest, containing 12 different 
specificities on nucleoside diphosphate (NDP) sugars that share a mechanism based on a transient 
keto intermediate (Table 1). This family is a rich pool of epimerases displaying diverse substrate and 
product specificities. Interestingly, this means that comparable active site architectures are able to 
bind different substrate molecules and yield varying reaction products. 
Based on the CEP classification, two C5-epimerases are present in the CEP1 family. These 
enzymes are of interest as they might contribute to the production of L-hexoses and derivatives, with 
applications as for instance antibiotics or nucleosides [4–6]. On the one hand, the double 
Catalysts 2020, 10, 222 2 of 11 
 
epimerization of GDP-mannose yielding GDP-L-galactose and GDP-L-gulose is catalyzed by GDP-
mannose 3,5-epimerase (GM35E, EC 5.1.3.18), an enzyme that has already been thoroughly 
characterized [7,8]. On the other hand, the UDP-glucuronate 5-epimerase specificity (UGA5E, EC 
5.1.3.12) would ensure the interconversion of UDP-D-glucuronic acid (UDP-GlcA) and UDP-L-
iduronic acid (UDP-IdoA) (Figure 1) [9]. This enzyme might be industrially relevant as UDP-IdoA is 
known as a precursor of heparin, a glycosaminoglycan (GAG) consisting of sulfated disaccharide 
repeating units of uronic acids (GlcA or IdoA) and D-glucosamine residues. This compound displays 
anticoagulant properties and is already practiced clinically [10,11]. Currently, the drug is isolated 
from animal tissue, yielding a heterogenous mixture [12]. However, research is focusing on the 
establishment of a (bio)chemical production process. One of the hurdles there is the synthetic access 
to L-iduronic acid and L-idose as building blocks [13]. In that respect, UGA5E might prove to be a 
very useful biocatalyst. In addition, the structural characterization of UGA5E might contribute to a 
better understanding of the CEP1 specificity determinants. Indeed, the comparison of the reaction 
mechanisms of GM35E and UGA5E could give more insight into the specific parameters that 
potentially promote or prevent a double epimerization, respectively.  
To date, UGA5E activity has only been detected in rabbit skin extracts, where the enzyme was 
believed to play a role in the synthesis of dermatan sulfate (DS, formerly chondroitin sulfate B) [9]. 
The structure of this GAG is comparable to heparin, but DS is composed of N-acetyl-D-galactosamine 
(GalNAc) building blocks instead of D-glucosamine residues [14]. Moreover, the IdoA subunits even 
function as key components in the binding site specificity for GAG-binding proteins [15]. The 
compound is expressed in various mammalian tissues and is involved in cardiovascular disease, 
tumorigenesis, infection, wound repair, and fibrosis. Jacobson et al. proposed a three-stage process 
for the production of this polysaccharide, starting from the conversion of UDP-glucose (UDP-Glc) to 
UDP-GlcA by the action of an UDP-glucose dehydrogenase. Next, UGA5E would catalyze the 
synthesis of UDP-IdoA from UDP-GlcA. Eventually, L-iduronic acid would be transferred to DS by 
a glycosyltransferase [9]. This pathway is comparable to that involving UDP-glucuronate 4-
epimerase (UGA4E, EC 5.1.3.6), an enzyme that catalyzes the interconversion of UDP-GlcA and UDP-
D-galacturonic acid (UDP-GalA) (Figure 1). The latter serves as a donor for GalA incorporation in 
plant cell walls, bacterial lipopolysaccharides, or antibiotics [16–20]. UGA4E is also present in the 
CEP1 family [3].  
Despite the detection of UGA5E activity in the tissue extracts, the respective gene was never 
identified or recombinantly expressed. Nevertheless, sequence databases contain various putative 
UGA5Es on which their assignment to the CEP1 family is based. On that account, this research 
focused on the analysis of these putative sequences and on the UGA5E specificity in general. 
Table 1. Overview of carbohydrate epimerase family 1. The specificities marked with an asterisk have 
a solved crystal structure. 
EC Number Specificity 
5.1.3.2 UDP-glucose 4-epimerase* 
5.1.3.10 CDP-paratose 2-epimerase* 
5.1.3.6 UDP-glucuronate 4-epimerase* 
5.1.3.7 UDP-N-acetylglucosamine 4-epimerase* 
5.1.3.16 UDP-glucosamine 4-epimerase 
5.1.3.25 dTDP-L-rhamnose 4-epimerase 
5.1.3.26 
N-acetyl-α-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 4-
epimerase 
5.1.3.5 UDP-L-arabinose 4-epimerase 
5.1.3.12 UDP-glucuronate 5-epimerase 
5.1.3.20 ADP-L-glyceromanno-heptose 6-epimerase* 
/ UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-4-hexulose 3-epimerase  
5.1.3.18 GDP-mannose 3,5-epimerase* 
Catalysts 2020, 10, 222 3 of 11 
 
 
Figure 1. Epimerization of UDP-glucuronic acid (UDP-GlcA) toward UDP-L-iduronic acid (UDP-
IdoA) and UDP-galacturonic acid (UDP-GalA) by UDP-glucuronate 5-epimerase (UGA5E) and UDP-
glucuronate 4-epimerase (UGA4E), respectively. 
2. Results 
2.1. Selection of a UGA5E Sequence 
The UniProt database contains 1154 putative ‘UDP-glucuronate 5-epimerase’ sequences, of 
which 20 are derived from eukaryotes, 10 from archaea, and the others from bacteria. One is even 
listed as a reviewed sequence, but this enzyme from Rhizobium meliloti (RmUGAE, UniProt: O54067) 
is most likely incorrectly annotated as the literature accompanying this entry actually discusses an 
UGA4E [21]. Consequently, this sequence was excluded from further analysis.  
As the UGA5E specificity might be valuable in an industrial context, a (thermo)stable 
representative from a bacterial source would be most relevant. Indeed, a bacterial variant should 
enable facilitated recombinant expression in prokaryotes, and (thermo)stability entails a higher 
tolerance for the harsh process conditions practiced in industry [22,23]. Therefore, the UniProt 
database was screened for UGA5E enzymes that meet these conditions. This analysis highlighted 
three promising sequences, namely, those from Thermacetogenium phaeum (UniProt: K4LEK1), 
Desulfurobacterium thermolithotrophum strain DSM 11699 (UniProt: F0S202), and 
Thermodesulfobacterium geofontis (UniProt: F8C4X8). The optimal growth temperatures of these 
organisms are 58, 70, and 83 °C, respectively [24–27]. For the current study, the highest temperature 
was selected, i.e., the putative UGA5E from T. geofontis (TgUGAE). 
2.2. Evaluation of TgUGAE 
First, the inducible expression of TgUGAE in E. coli was evaluated and seemed to be the highest 
at an incubation temperature of 20 °C (Figure S1). As it was found that the enzyme was mainly 
expressed in the insoluble fraction, activity tests were performed with crude cell lysate. The 
conversion of UDP-GlcA was followed over time and the formation of one reaction product was 
observed. The retention time of the hydrolyzed product on HPLC corresponded to that of GalA, the 
C4-epimer of GlcA (Figure 2). Further analysis confirmed that this detected UGA4E activity was 
derived from the overexpressed TgUGAE sequence and not from the accompanying E. coli 
background (Figure S2). The possibility that the biocatalyst would display a side activity as C5-
epimerase was disproved as no extra product was obtained, even after extensive incubation and 
spiking the reaction with fresh lysate. Furthermore, activity tests with purified enzyme and 5 mM 
additional NAD+ resulted in the same reaction profile. The extra peak in the chromatogram at 5.70 
min was also present in control samples and was, thus, not the result of any enzymatic activity (Figure 
S3). Consequently, it could be concluded that the putative UGA5E sequence from 
Thermodesulfobacterium geofontis is actually an UGA4E, with a specific activity of 1.7 (± 0.2) U/mg 
(using 10 mM UDP-GlcA at pH 7.5 and 30 °C). 
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Figure 2. Product formation by TgUGAE crude cell lysate. (a) Chromatographic analysis of the 
reaction mixture (blue). The peaks were compared to known standards (black). The nucleoside 
diphosphate (NDP)-sugars of the reaction mixture were hydrolyzed to their respective 
monosaccharides prior to analysis. GalA: galacturonic acid; GlcA: glucuronic acid; IdoA: L-iduronic 
acid. (b) Conversion of UDP-glucuronic acid toward UDP-galacturonic acid over time. 
2.3. In Silico Analysis of the UGA5E Specificity 
The further quest for a true UGA5E was assisted by an in silico approach. Commonly, unknown 
genes are annotated based on sequence similarities. As no reference sequence is available for UGA5E, 
the annotation of potential UGA5E sequences is rather arbitrary. The hypothesized UGA5E 
specificity, and the CEP1 family, in general, is part of the short-chain dehydrogenase/reductase (SDR) 
superfamily, a large cluster of NAD(P)(H)-dependent oxidoreductases [3,28]. Members of this family 
display low sequence identities (typically 15–30%), though they share some common motifs such as 
an GxxGxxG motif for NAD(P)+ binding within a Rossmann fold and an YxxxK catalytic motif. Based 
on these features, sequences can be classified in the SDR superfamily. Subsequently, specific 
conserved residues and secondary structures can contribute to the distinction of various enzymatic 
specificities, e.g., the conserved catalytic cysteine and lysine in GM35E [8]. Due to the lack of a 
reference sequence for UGA5E, the determination of these specific conserved residues is thus 
unachievable at the moment. On that account, the actual function of the putative UGA5E sequences 
is dubious. 
This statement is clearly demonstrated when performing a Basic Local Alignment Search Tool 
(BLAST) analysis with the TgUGAE sequence. Indeed, 19% of the resulting sequences are annotated 
as ‘NAD-dependent epimerase/dehydratase/oxidoreductase,’ which implies that they are part of the 
SDR superfamily and this annotation is, thus, most probably based on the sequence motifs. Another 
72% of the BLAST outcome consists of ‘NDP-sugar epimerase’ annotated sequences. The remaining 
results (9%) comprise a variety of specific epimerases, such as UGA5Es and UGA4Es. 
In order to find a sequence with a high probability of being an UGA5E, a phylogenetic tree of all 
putative UGA5E sequences was constructed (Figure 3). Next, ten bacterial sequences from around 
the tree were randomly selected for further investigation. A BLAST search was performed with each 
of the sequences and the ratio of ‘UDP-glucuronate 5-epimerase’ as the outcome compared to all 
results was analyzed (Figure 4). It was hypothesized that enzymes with a high ratio have a bigger 
chance to display the UGA5E specificity as the annotation is based on a common feature among the 
putative UGA5E sequences. Accordingly, the UGA5E from Agrobacterium radiobacter strain K84 
(ArUGAE, UniProt: B9J8R3) was selected as being the sequence with the highest ratio (59%). 
Interestingly, according to this analysis, TgUGAE displayed a very low ratio of only 3%. The fact that 
this enzyme was then actually a C4-epimerase substantiates the above reasoning. 
Catalysts 2020, 10, 222 5 of 11 
 
 
Figure 3. Phylogenetic tree of the putative UGA5E sequences present in the UniProt database. 
Eukaryotic sequences are colored in green, whereas the sequences derived from archaea are 
highlighted in blue. A BLAST search was performed with the sequences represented in orange. 
TgUGAE is presented in red. The arrows indicate the sequences that were experimentally tested in 
this research. 
 
Figure 4. Ratio of ‘UDP-glucuronate 5-epimerase’ sequences in the BLAST results of the randomly 
selected putative UGA5E sequences. The sequences are represented by their UniProt entry. TgUGAE 
is indicated by an arrow. 
2.4. Evaluation of ArUGAE 
The recombinant expression of ArUGAE was, again, first evaluated, and an incubation 
temperature of 20 °C was found to be most suitable (Figure S4). As was the case for TgUGAE, the 
enzyme was mainly present in the insoluble fraction and, thus, the activity tests were performed with 
crude cell lysate. As can be seen in Figure 5, this enzyme also catalyzes the interconversion of UDP-
GlcA and UDP-GalA and thus displays an UGA4E specificity instead of the hypothesized UGA5E 
specificity. Again, extra controls were included to eliminate the possibility that the UGA4E activity 
was derived from the E. coli background and to assign the extra peak in the chromatogram (Figures 
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S5 and S6). Moreover, the addition of NAD+ had no influence on the epimerization specificity. 
Accordingly, this sequence from Agrobacterium radiobacter should be designated as UGA4E. The 
enzyme displayed a specific activity of 12.6 (± 1.2) U/mg (using 10 mM UDP-GlcA at pH 7.5 and 30 
°C). 
 
Figure 5. Specificity testing of ArUGAE crude cell lysate. (a) Product analysis on HPLC of the 
ArUGAE reaction mixture (blue). Standards are represented in black. The reaction mixture was 
hydrolyzed prior to analysis to obtain free monosaccharides. GalA: galacturonic acid; GlcA: 
glucuronic acid; IdoA: L-iduronic acid. (b) Conversion of UDP-glucuronic acid to UDP-galacturonic 
acid over time.  
2.5. Analysis of the UGA5E Specificity 
Both examined putative UGA5E sequences actually appeared to be UGA4Es. These findings 
raise questions about the specificity of the other sequences in the phylogenetic tree. ArUGAE was 
selected based on its high UGA5E ratio among the BLAST results. However, it is very likely that the 
presumed UGA5E from Rhizobium meliloti, which actually is an UGA4E, was used as a reference for 
annotation. Consequently, this would mean that UGA4E-specific features are assigned to the 
hypothesized UGA5E specificity. Accordingly, chances were high that ArUGAE displayed the 
UGA4E specificity. In addition, detailed analysis of the BLAST results of ArUGAE showed that 
RmUGAE was one of the outcomes. When a reverse reasoning is applied, this would mean that 
sequences with a low UGA5E ratio are more likely to actually display UGA5E specificity. 
Nevertheless, even though the ratio of TgUGAE was indeed low, the enzyme still displayed UGA4E 
activity. Taking into account the fact that both epimerases are located in different clades of the 
phylogenetic tree, it is hypothesized that the UGA4E specificity can be assigned to all of these 
sequences.  
This hypothesis is supported by a more detailed sequence analysis. Sun et al. recently solved the 
first crystal structure of an UGA4E (i.e., from Streptomyces viridosporus, PDB 6KV9) and found that 
crucial interactions are formed with the substrate at positions G92 and R192 [20]. Moreover, R192 is 
believed to favor the sugar ring rotation that is needed for C4-epimerization, and its correct 
orientation would be ensured by the adjacent D194. The conservation of these residues, and their 
environment, in all of the UGA4Es characterized to date is displayed in Figure 6. Crucially, the 
sequence logo of the putative UGA5E sequences is found to be practically identical. In order to make 
a comparison to a related C5-epimerase, GM35E from the same CEP1 family was analyzed as well. 
In addition, the sequence logo of UDP-glucose 4-epimerase (Gal4E), the most studied specificity 
within the CEP1 family, was also included. As a totally different sequence logo was obtained for the 
latter two epimerases, it can be concluded that the residues are not simply conserved among all CEP1 
members or even among enzymes with the same epimerization site. Accordingly, G92, R192, and 
D194 can probably serve as fingerprints for the UGA4E specificity. In addition, similar differences 
are observed in the YxxxK catalytic motif (Figure 6). These results indicate that the putative UGA5E 
sequences are probably just incorrectly annotated UGA4Es. 
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Figure 6. Overview of sequence logos. The conservation of various active site residues, including their 
environment, and the YxxxK motif were evaluated for UDP-glucuronate 4-epimerase (UGA4E), 
putative UDP-glucuronate 5-epimerase (UGA5E), GDP-mannose 3,5 epimerase (GM35E), and UDP-
glucose 4-epimerase (Gal4E). Residues are numbered according to the UGA4E from Streptomyces 
viridosporus. 
3. Discussion 
Carbohydrate epimerases have recently come into focus as they are a valuable route toward rare 
sugar production. However, more research on this enzyme class is required in order to fully 
appreciate their potential. Even though 39 specificities have been discovered to date, in-depth 
information on these enzymes’ physiological roles or catalytic mechanisms is often lacking. 
Therefore, efforts should be made to characterize representatives in order to fill in these knowledge 
gaps. Moreover, prominent mechanistic insights might lead to the rational engineering of these 
biocatalysts, potentially resulting in altered specificities, stabilities, or activities. 
On that account, this study focused on the UGA5E specificity, hypothesized to catalyze the 
reversible epimerization of UDP-GlcA toward UDP-IdoA [9]. The enzyme’s activity was only 
detected in rabbit tissue before, and there is no report on the recombinant expression or 
characterization of a putative UGA5E to date. This research clustered all 1154 putative UGA5E 
sequences from the UniProt database in a phylogenetic tree and the combination of experimental 
work and in silico analysis resulted in the hypothesis that these sequences actually display UGA4E 
specificity. Subsequently, the existence of the UGA5E specificity in general was questioned, resulting 
in a physiological issue. Indeed, it was previously hypothesized that UGA5E is part of the enzymatic 
pathway for the production of IdoA-containing DS starting from UDP-Glc (Figure 7a) [9]. To shed 
more light on this issue, pathways relevant for other eukaryotic and prokaryotic IdoA-containing 
polysaccharides, e.g., heparin sulfate, were examined [11,14,29]. These metabolic pathways start with 
the action of an UDP-Glc dehydrogenase, converting UDP-Glc into UDP-GlcA. However, this sugar 
acid is then first polymerized before the resulting polysaccharide undergoes modifications such as 
sulfation or epimerization. In other words, GlcA is, thus, epimerized to IdoA at the polysaccharide 
level instead of at the NDP-sugar level. For the bacterial GAGs structures and heparin/heparan 
sulfate, this epimerization step is catalyzed by an enzyme referred to as glucuronyl C5-epimerase (EC 
5.1.3.17, CEP8) [30,31]. For dermatan and chondroitin sulfate synthesis, it was found that this reaction 
is realized by chondroitin-glucuronate C5-epimerase (EC 5.1.3.19, not classified in a CEP family) 
[32,33].  
These results thus contradict the hypothesis of Jacobson et al., although the outcomes can be 
unified [9]. Indeed, the detected UDP-glucose dehydrogenase activity is anyway present as the first 
step in the pathway in order to obtain UDP-GlcA. Subsequently, the assumed UGA5E activity can be 
explained by the fact that they analyzed protein fractions and not purified proteins. The detected 
UGA5E activity in such a fraction was, thus, most probably the combined action of a 
glycosyltransferase that catalyzes the polymerization and chondroitin-glucuronate C5-epimerase, 
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resulting in IdoA subunits (Figure 7b). Subsequently, the polysaccharide can be further sulfated, 
eventually yielding DS. In general, the probability of the presence of the UGA5E specificity in nature 
is further decreased by the observation that no additional functions for free (UDP-)L-iduronic acid 
have been detected to date and no extra evidence on this epimerase specificity has been published 
since 1962.  
In conclusion, this research states that the assumed UGA5E specificity present in sequence 
databases is not justified, and that the corresponding EC entry should be retracted. The epimerase 
specificity was initially studied as a potential route toward IdoA production, which can then be used 
for the synthesis of heparin. On that account, an enzymatic route comprising chondroitin-glucuronate 
C5-epimerase or glucuronyl C5-epimerase can still be exploited. In addition, this study unlocks a new 
pool of UGA4E sequences, which can be deployed for UDP-GalA synthesis, and has highlighted 
fingerprints that could be used for the correct annotation of sequences harboring UGA4E activity. 
  
Figure 7. Production of dermatan sulfate. (a) Hypothesized pathway containing the putative UGA5E 
specificity versus (b) confirmed pathway on a polysaccharide level. Glc: glucose; GlcA: glucuronic 
acid; GalNAc: N-acetyl-D-galactosamine; IdoA: L-iduronic acid; DH: UDP-glucose dehydrogenase; 
UGA5E: UDP-glucuronate 5-epimerase; GT: glycosyltransferase; C5-epi: chondroitin-glucuronate C5-
epimerase.  
4. Materials and Methods  
4.1. Materials 
All chemicals were obtained from Sigma-Aldrich (Saint Lois, MO, USA) or Carbosynth 
(Compton, UK) and were of the highest purity, unless stated otherwise. 
4.2. Gene Cloning and Transformation 
The codon-optimized putative UGA5E genes from Thermodesulfobacterium geofontis (UniProt: 
F8C4X8) and Agrobacterium radiobacter strain K84 (UniProt: B9J8R3) were synthesized and subcloned 
into the pET21 vector at NdeI and XhoI restriction sites, providing a C-terminal His6-tag, by GeneArt 
Gene Synthesis (Thermo Fisher Scientific, Waltham, MA, USA). The constructs were transformed in 
E. coli BL21(DE3) electrocompetent cells for protein expression. 
4.3. Enzyme Production 
First, 250 mL lysogeny broth (LB) medium (10 g/L trypton, 5 g/L yeast extract and 5 g/L NaCl) 
supplemented with 100 µg/mL ampicillin was inoculated with 2% (v/v) stationary culture and 
incubated at 37 °C and 200 rpm until the OD600 equaled 0.6. Subsequently, enzyme production was 
induced by the addition of isopropyl β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 
mM and the culture was incubated overnight at 20 °C and 200 rpm. Cells were harvested by 
centrifuging for 30 min at 9000 rpm and 4 °C. The obtained pellet was frozen and stored at –20 °C for 
at least 1 h. 
In order to obtain crude cell lysate for the initial specificity tests, the pellet was resuspended in 
8 mL of lysis buffer (10 mM imidazole and 100 µM phenylmethane sulfonyl fluoride (PMSF) in 100 
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mM MOPS pH 7.5) and cooled on ice for 30 min. Subsequently, the cells were further disrupted by 
sonication (3 times 2.5 min, Branson sonifier 250, level 3, 50% duty cycle).  
On the other hand, purified enzyme was obtained by first lysing the cells by resuspending the 
pellet in 8 mL of lysis buffer (500 mM NaCl, 10 mM imidazole, 100 µM PMSF, and 1 mg/mL lysozyme 
in 50 mM sodium phosphate buffer pH 7.4) and cooling them on ice for 30 min. Next, the cells were 
subjected to 3 times 2.5 min of sonication (Branson sonifier 250, level 3, 50% duty cycle). Cell debris 
was collected by 15 min of centrifugation at 12000 rpm and 4 °C. Next, the His6-tagged proteins 
present in the supernatant were purified to apparent homogeneity by nickel-nitrilotriacetic acid 
chromatography, with small variations to the supplier’s description (Thermo Scientific, Waltham, 
MA, USA). The resin was washed twice with 8 mL wash buffer (500 mM NaCl, 20 mM imidazole in 
50 mM sodium phosphate buffer pH 7.4). Protein was eluted with 3 times 4 mL elution buffer (500 
mM NaCl, 250 mM imidazole in 50 mM sodium phosphate buffer pH 7.4). As a final step, buffer was 
exchanged to 100 mM MOPS pH 7.5 by using Amicon Ultra-15 centrifugal filter units with 30 kDa 
cut-off (Merck Millipore, Darmstadt, Germany). For TgUGAE, the purification yield was only 0.2 
mg/L culture, whereas for ArUGAE, this was about 45 mg/L (Figures S7 and S8).  
The protein content was determined by measuring the absorbance at 280 nm with the 
NanoDrop2000 Spectrophotometer (Thermo Scientific, Waltham, MA, USA). The extinction 
coefficient and molecular weight of His6-tagged enzymes were calculated using the ProtParam tool 
on the ExPASy server (https://web.expasy.org/protparam/). Molecular weight and purity of the 
protein were verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE; 12% 
gel). As the expression of TgUGAE was low, the measured protein concentration was adjusted using 
the ImageJ software [34]. 
4.4. Activity Testing 
For the examination of the putative UGA5Es, 10 mM UDP-GlcA was incubated together with 
100 µL crude cell lysate in 100 mM MOPS pH 7.5 at 30 °C (500 µL total reaction volume). A substrate 
control (10 mM UDP-GlcA in 100 mM MOPS pH 7.5), as well as an enzyme control (100 µL crude cell 
lysate in 100 mM MOPS pH 7.5) were included and treated in the exact same way as the reaction 
mixture. Tests were performed in triplicate. In addition, the potential activity of the background 
proteins was tested by setting up a reaction with 10 mM UDP-GlcA and 100 µL crude cell lysate 
obtained from induced E. coli BL21(DE3) cells containing an empty pET21 vector in 100 mM MOPS 
pH 7.5 at 30 °C. The influence of NAD+ on the enzyme’s specificity was tested by incubating 0.1 
mg/mL enzyme with 10 mM UDP-GlcA and 5 mM NAD+ in 100 mM MOPS pH 7.5 at 30 °C (400 µL 
total reaction volume). The enzymes’ specific activities were determined with 10 mM UDP-GlcA and 
0.05 mg/mL purified enzyme in a total reaction volume of 300 µL 100 mM MOPS pH 7.5 at 30 °C. For 
all activity tests, samples were taken at defined time points and inactivated in 90 mM acetic acid. The 
samples were then hydrolyzed for 1 h at 95 °C in order to obtain the respective monosaccharides. The 
hydrolyzed reaction mixtures were analyzed using high-performance anion exchange 
chromatography and pulsed amperometric detection (HPAEC-PAD; Dionex ICS-3000 system, 
Thermo Fisher Scientific, Waltham, MA, USA). The separation of the various uronic acids was 
realized by an isocratic method using a mixture of 150 mM NaOAch and 100 mM NaOH for 10 min. 
4.5. Sequence Analysis 
All amino acid sequences annotated as ‘UDP-glucuronate 5-epimerase’ were retrieved from the 
UniProt database (https://www.uniprot.org) and subsequently aligned with Clustal Omega using 
default parameters (https://www.ebi.ac.uk/Tools/msa/clustalo/) [35]. The concomitant phylogenetic 
tree was visualized with iTOL (https://itol.embl.de). BLAST analyses were performed at the UniProt 
server using default parameters. For the sequence logos, the sequences of the characterized UGA4Es, 
GM35Es, and Gal4Es were extracted from the UniProt database and aligned with Clustal Omega 
using default parameters. Subsequently, the sequence logos were generated by WebLogo [36]. 
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